Department of Justice March 23, 2010 – Federal Register Recent Federal Regulation Documents

Commutation of Sentence: Technical Change
Document Number: 2010-6290
Type: Rule
Date: 2010-03-23
Agency: Department of Justice, Bureau of Prisons, Prisons Bureau
This document makes a minor technical change to the Bureau of Prisons (Bureau) regulations on sentence commutation to clarify that the Bureau staff, who may not be institution-level staff, will recalculate the inmate's sentence in accordance with the terms of the commutation order if a petition for commutation of sentence is granted.
Inmate Access to Inmate Central File: PSRs and SORs
Document Number: 2010-6288
Type: Proposed Rule
Date: 2010-03-23
Agency: Department of Justice, Bureau of Prisons, Prisons Bureau
The Bureau of Prisons (Bureau) proposes to amend regulations regarding inmate access to Inmate Central File materials to prohibit sentenced inmates incarcerated in Bureau facilities, including those in contract facilities or community confinement, from possessing their Pre-Sentence Investigation Reports (PSRs), Statements of Reasons (SORs), or other similar sentencing documents from criminal judgments. Such inmates under this prohibition will continue to be permitted to review their PSRs and SORs.
Schedules of Controlled Substances; Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhalers Manufactured by Classic Pharmaceuticals, LLC
Document Number: 2010-6176
Type: Rule
Date: 2010-03-23
Agency: Drug Enforcement Administration, Department of Justice
Under this Final Rule, the Drug Enforcement Administration (DEA) is updating the Table of Excluded Nonnarcotic Products found in 21 CFR 1308.22 to include the Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 mg Levmetamfetamine) manufactured by Classic Pharmaceuticals, LLC and marketed under various private labels (to include the ``Premier Value'' and ``Kroger'' labels). This nonnarcotic drug product, which may be lawfully sold over the counter without a prescription under the Federal Food, Drug, and Cosmetic Act, is excluded from provisions of the Controlled Substances Act (CSA) pursuant to 21 U.S.C. 811(g)(1).
Implementation of the Methamphetamine Production Prevention Act of 2008
Document Number: 2010-6175
Type: Proposed Rule
Date: 2010-03-23
Agency: Drug Enforcement Administration, Department of Justice
In October 2008, the President signed the Methamphetamine Production Prevention Act of 2008, which clarifies the information entry and signature requirements for electronic logbook systems permitted for the retail sale of scheduled listed chemical products. DEA is promulgating this rule to incorporate the statutory provisions and make its regulations consistent with the new requirements. Once finalized, this action will make it easier for regulated sellers to maintain electronic logbooks by allowing greater flexibility as to how information may be captured.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.